Stay updated with breaking news from Jiangbing zhou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Couragene Co-founders Developing Gene Editing Technology for Genetic Diseases Awarded Major Federal Grant streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NORTH BRUNSWICK, N.J. (BUSINESS WIRE) Couragene, a genetic medicines company using novel delivery platforms, announces today that its co-founders Yong-Hui Jiang and Jiangbing Zhou of Yale University, together with Elizabeth Berry-Kravis of RUSH University have been awarded a competitive UG3/UH3 grant from the NIH’. ....
The two-phase grant will support research into a novel CRISPR-based gene-editing technology and delivery platform for targeting neurogenetic diseases. ....
The National Institute of Health announced a $40 million grant for researchers to develop a CRISPR-mediated platform for genome editing in the brain and to treat genetic disorders. ....
Yale Researchers Recognized with Yale Faculty Innovation Awards yale.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yale.edu Daily Mail and Mail on Sunday newspapers.